{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:25:53Z","timestamp":1787016353036,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1124\/dmd.121.000646","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T14:41:01Z","timestamp":1635864061000},"page":"168-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Impact of Age and Genetics on Naltrexone Biotransformation"],"prefix":"10.1016","volume":"50","author":[{"given":"Stephani L.","family":"Stancil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin E.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent S.","family":"Staggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steven","family":"Leeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000646_bib1","unstructured":"Database of Single Nucleotide Polymorphisms (dbSNP). Bethesda (MD): National Center for Biotechnology Information, National Library of Medicine. dbSNP accession:{rs3829125, rs17134592}, (dbSNP Build ID: {GRCh38.p12}). Available from: http:\/\/www.ncbi.nlm.nih.gov\/SNP\/."},{"key":"10.1124\/dmd.121.000646_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.121.000646_bib4","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1211\/0022357045020","article-title":"Carbonyl reduction of naltrexone and dolasetron by oxidoreductases isolated from human liver cytosol","volume":"56","author":"Breyer-Pfaff","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.121.000646_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1530-0277.2006.00052.x","article-title":"Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone","volume":"30","author":"Dunbar","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/dmd.121.000646_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00004583-199905000-00021","article-title":"Naltrexone and communication skills in young children with autism","volume":"38","author":"Feldman","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.121.000646_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology--drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.121.000646_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004583-199502000-00018","article-title":"Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study","volume":"34","author":"Kolmen","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.121.000646_bib9","first-page":"1570","article-title":"Naltrexone in young autistic children: replication study and learning measures","volume":"36","author":"Kolmen","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1124\/dmd.121.000646_bib10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1124\/jpet.103.060137","article-title":"Developmental expression of human hepatic CYP2C9 and CYP2C19","volume":"308","author":"Koukouritaki","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000646_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1203\/00006450-200202000-00018","article-title":"Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression","volume":"51","author":"Koukouritaki","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1124\/dmd.121.000646_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00008571-199912000-00011","article-title":"Characterization of a novel variant (S145C\/L311V) of 3alpha-hydroxysteroid\/dihydrodiol dehydrogenase in human liver","volume":"9","author":"Kume","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.121.000646_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0076-6879(78)52021-1","article-title":"Purification and assay of liver microsomal epoxide hydrase","volume":"52","author":"Lu","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.121.000646_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0893-133X(02)00368-8","article-title":"A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone","volume":"27","author":"Mason","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/dmd.121.000646_bib15","first-page":"1385","article-title":"Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers","volume":"24","author":"McCaul","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/dmd.121.000646_bib16","first-page":"15","article-title":"Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration","volume":"45","author":"Meyer","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/dmd.121.000646_bib17","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2009.27.2153","article-title":"Chlordecone exposure and risk of prostate cancer","volume":"28","author":"Multigner","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.121.000646_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1101\/gr.9.8.677","article-title":"dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation","volume":"9","author":"Sherry","year":"1999","journal-title":"Genome Res"},{"key":"10.1124\/dmd.121.000646_bib21","first-page":"675","article-title":"Developmental considerations for the use of naltrexone in children and adolescents","volume":"26","author":"Stancil","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1124\/dmd.121.000646_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/cap.2019.0056","article-title":"Naltrexone reduces binge eating and purging in adolescents in an eating disorder program","volume":"29","author":"Stancil","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1124\/dmd.121.000646_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.103.054841","article-title":"Developmental expression of the major human hepatic CYP3A enzymes","volume":"307","author":"Stevens","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000646_bib24","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1124\/dmd.108.021873","article-title":"Developmental changes in human liver CYP2D6 expression","volume":"36","author":"Stevens","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000646_bib25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0006-3223(95)00297-9","article-title":"The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study","volume":"39","author":"Willemsen-Swinkels","year":"1996","journal-title":"Biol Psychiatry"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624007384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:51:48Z","timestamp":1739937108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624007384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0090955624007384"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000646","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Age and Genetics on Naltrexone Biotransformation","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}